Funded Startups in Del Mar
Del Mar’s most recent funded rounds show a wide disclosed range: the largest disclosed amount is Antiva Biosciences at $53M (2023-04-27), which sits well a…
Del Mar’s most recent funded rounds show a wide disclosed range: the largest disclosed amount is Antiva Biosciences at $53M (2023-04-27), which sits well above other disclosed rounds in this view, including Lenz Therapeutics at $49M (2022-11-22) and Turnout at $35M (2026-06-11). The only other clearly large disclosed entry is Channel Robotics at $5M (2026-06-18), while several deals cluster at the low end such as TradeSun at $100K (2020-12-10) and the $1M/ $2M rounds (Humetrix on 2022-05-05 for $1M; SAIL Fusion on 2023-04-13 for $2M).
Date and category are clustered as well. All 10 rows are Del Mar, California, except two entries labeled “Del Mar, United States” without a state, and the timeline spans 2020-07-21 (Selva Therapeutics) to 2026-06-18 (Channel Robotics). Four of the 10 entries fall in 2022–2023 (Lenz Therapeutics $49M on 2022-11-22; Humetrix $1M on 2022-05-05; CeleCor Therapeutics $3M on 2022-03-08; Antiva Biosciences $53M on 2023-04-27; SAIL Fusion $2M on 2023-04-13), and sector concentration is skewed toward Biotechnology (3 entries: Antiva Biosciences, CeleCor Therapeutics, Selva Therapeutics). Stage disclosures are incomplete: 2 entries are “undisclosed” (Global Air Logistics and Training on 2026-04-01; none others) and 4 entries carry “Series Unknown” variants (including 2023 and 2022 deals).
Most recent rounds
10 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Del Mar list, and how much larger is it than the rest?
Antiva Biosciences at $53M (2023-04-27) is the top disclosed amount here, with Lenz Therapeutics following at $49M (2022-11-22) and Turnout at $35M (2026-06-11). The rest of the disclosed rounds mostly sit far below $35M, including $5M for Channel Robotics (2026-06-18) and $100K for TradeSun (2020-12-10).
Are the disclosed rounds clustered in a narrow time window, or spread out evenly across years?
They’re spread across 2020-07-21 (Selva Therapeutics) through 2026-06-18 (Channel Robotics), but there is noticeable concentration in 2022–2023: CeleCor Therapeutics ($3M, 2022-03-08), Humetrix ($1M, 2022-05-05), Lenz Therapeutics ($49M, 2022-11-22), SAIL Fusion ($2M, 2023-04-13), and Antiva Biosciences ($53M, 2023-04-27).
Which sectors appear most often in this view, and does any sector pair with the largest disclosed deals?
Biotechnology is the most represented sector with 3 entries (Antiva Biosciences $53M on 2023-04-27; CeleCor Therapeutics $3M on 2022-03-08; Selva Therapeutics $3M on 2020-07-21). The two largest disclosed amounts ($53M and $49M on 2023-04-27 and 2022-11-22) correspond to Biotechnology and Pharmaceutical Manufacturing, respectively.
Which stage labels dominate, and how often are amounts or stages not specified?
Stage labeling is mixed and incomplete: 4 entries are marked “Series Unknown” (including SAIL Fusion 2023-04-13 for $2M; Lenz Therapeutics 2022-11-22 for $49M; Humetrix 2022-05-05 for $1M; CeleCor Therapeutics 2022-03-08 for $3M), while 1 entry is explicitly “undisclosed” by amount (Global Air Logistics and Training on 2026-04-01). Only 2 entries show clear named stages beyond “Series Unknown” variants: Turnout is “Series A” ($35M on 2026-06-11) and Antiva Biosciences is “Series E” ($53M on 2023-04-27).
Are there outliers worth noting, either by deal size or by being dramatically smaller than the rest?
TradeSun at $100K (2020-12-10) is a clear low-end outlier versus the other disclosed amounts, which include $1M–$5M entries (Humetrix $1M on 2022-05-05; SAIL Fusion $2M on 2023-04-13; CeleCor Therapeutics $3M on 2022-03-08; Selva Therapeutics $3M on 2020-07-21; Channel Robotics $5M on 2026-06-18). At the high end, Antiva Biosciences ($53M on 2023-04-27) and Lenz Therapeutics ($49M on 2022-11-22) are separated from the mid-tier like Turnout at $35M (2026-06-11).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.